Albemarle price to sales ratio ALB
Market value divided by revenue over the last twelve months, since 2011.
- Today, Oct 23, 2026
- 1.9×
- 10-year median
- 3.1×
- Against its 10-year history
- 19th
- percentile: 0 is its lowest day, 100 its highest
- 10-year range
- 1.2× to 9.9×
- Peer median
- 2.6×
Albemarle's price to sales ratio is 1.9× as of Oct 23, 2026.
That is below its ten-year median of 3.1×, lower than on 81% of days in the last ten years.
Over that time it ranged from 1.2× in Apr 2025 to 9.9× in Nov 2021.
The median for 10 chemicals stocks of a similar size is 2.6×.
Price to sales ratio over time
The dashed line is the 10-year median and the shaded band the middle half of its days.
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 1.9× | 1.9× | 4.5× |
| 2025 | 3.6× | 1.2× | 3.6× |
| 2024 | 1.6× | 1.2× | 2.0× |
| 2023 | 1.7× | 1.4× | 6.0× |
| 2022 | 4.5× | 4.5× | 8.7× |
| 2021 | 8.3× | 5.1× | 9.9× |
| 2020 | 4.8× | 1.6× | 4.9× |
| 2019 | 2.2× | 1.9× | 2.9× |
| 2018 | 2.5× | 2.4× | 5.1× |
| 2017 | 4.9× | 3.3× | 5.5× |
| 2016 | 3.1× | 1.6× | 3.3× |
| 2015 | 1.9× | 1.5× | 2.9× |
| 2014 | 1.8× | 1.6× | 2.2× |
| 2013 | 2.0× | 1.9× | 2.2× |
| 2012 | 2.0× | 1.6× | 2.1× |
| 2011 | 1.7× | 1.4× | 2.6× |
Against its peers
Companies in Chemicals nearest Albemarle's size, closest first, today.
| Company | Price to sales ratio |
|---|---|
| ALBAlbemarle | 1.9× |
| ESIElement Solutions | 2.6× |
| EMNEastman Chemical | 0.8× |
| DDDuPont de Nemours | 2.6× |
| HXLHexcel | 3.0× |
| BCPCBalchem | 5.2× |
| DOWDow | 0.6× |
| CSWCSW Industrials | 4.1× |
| CBTCabot | 1.0× |
| AVNTAvient | 1.1× |
| WDFCWD 40 | 4.2× |
| Peer median | 2.6× |
Where Albemarle ranks
What the price to sales ratio tells you
Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.
Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.
More on Albemarle
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.